Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,430.59
(
-0.94%
)
US TECH 100
28,440.20
(
-1.22%
)
Dow Jones
49,572.47
(
-0.98%
)
Brent Oil
106.61
(
2.33%
)
Bitcoin
79,236.42
(
-2.25%
)
News Focus
News Focus
Post# of 257574
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122986
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biomaven0 post# 143359

Wednesday, 06/06/2012 11:22:31 AM

Wednesday, June 06, 2012 11:22:31 AM

Post# of 257574
Roche’s ADACTA study of Actemra vs Humira under-dosed patients in the Humira arm by giving them 40mg bi-weekly in strict accordance with the FDA label. When Humira is used in RA without methotrexate, as it was in this trial, the de facto dose is 40mg weekly rather than bi-weekly.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today